roche holding ag-genusschein
(ROG:SIX Swiss Ex)
Executive Profile*
Ian T. ClarkHead of Global Product Strategy and Chief Executive Officer of Genentech, Roche Holding AG |
| Age | Total Calculated Compensation | This person is connected to 136 board members in 3 different organizations across 5 different industries. See Board Relationships |
| 51 | -- |
Background*
Mr. Ian T. Clark has been the Head of Global Product Strategy at Roche Holding AG since January 2010. Mr. Clark serves as the Chief Executive Officer of South San Francisco biotech. He serves as the Chief Executive Officer and Head of North American Commercial Operations at Genentech, Inc. He served as the Chief Marketing Officer and Head of Global Product Strategy of Genentech Inc., and at Roche, Pharma Division. Mr. Clark served as Executive Vice President of Commercial ...
Corporate Headquarters*Grenzacherstrasse 124Basel, Basel-Stadt 4070 Switzerland Phone: 41 61 688 11 11 Fax: 41 61 691 93 91 Board Members Memberships*Chief Executive Officer, Head of North American Commercial Operations, Director and Member of Executive Committee Director At Large 2007-2009 Former Non-Executive Director, Member of Audit Committee, Member of Remuneration Committee and Member of Nominations & Corporate Governance Committee 2009-2010 Former Director and Member of Corporate Governance Committee 2011-Present Independent Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
Education*BS University of Southampton
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| ROG:VX | SFr.253.10 CHF | +2.40 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Ian C. Read | Chairman, Chief Executive Officer and Chairman of Executive Committee Pfizer Inc. | $1.7M |
| Andrew Philip Witty | Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee GlaxoSmithKline plc | 1.9M GBP |
| Kenneth C. Frazier | Chairman, Chief Executive Officer and President Merck & Co. Inc. | $1.5M |
| Joseph Jimenez MBA | Chief Executive Officer and Member of Executive Committee Novartis AG | SFr.3.4M |
| Christopher A. Viehbacher | Chief Executive Officer, Director and Member of Strategy Committee Sanofi | €3.5M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Chandler, AZ | RogersPosted: Apr 23
- Woodstock, CT | RogersPosted: May 24
- Cleveland, OH | Rogers GroupPosted: May 17
- Mentor, OH | Rogers GroupPosted: May 16
Sponsored Financial Commentaries
Sponsored Links
To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
